Ratings by Needham (Serge Belanger)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/13/2024 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2024 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2024 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2023 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2023 | Moonlake Immunotherapeutics | MLTX | New Coverage | Buy (N/A) |
56.19 (42.25) |
-24.81% | Details | |
| 8/25/2023 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2023 | Verrica Pharmaceuticals | VRCA | Upgrade | Buy (Hold) |
5.11 (6.90) |
35.03% | Details | |
| 6/26/2023 | DICE Therapeutics | DICE | Downgrade | Hold (Buy) |
46.61 (47.55) |
2.02% | Details | |
| 5/10/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2023 | DICE Therapeutics | DICE | New Coverage | Buy (N/A) |
28.68 (47.55) |
65.79% | Details | |
| 3/24/2023 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2023 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Clearside Biomedical | CLSD | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2023 | BioCryst Pharma | BCRX | Upgrade | Buy (Hold) |
8.64 (4.50) |
-47.92% | Details | |
| 1/10/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2023 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2022 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
27.88 (15.16) |
-45.62% | Details | |
| 11/11/2022 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Clearside Biomedical | CLSD | Upgrade | Buy (Hold) |
1.28 (1.32) |
3.13% | Details | |
| 11/9/2022 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | Tricida | TCDA | Downgrade | Hold (Buy) |
10.88 (0.11) |
-98.99% | Details | |
| 9/28/2022 | PhaseBio Pharmaceuticals Inc. | PHAS | Downgrade | Hold (Buy) |
0.76 (0.07) |
-90.79% | Details | |
| 9/8/2022 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2022 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2022 | Aerie Pharma | AERI | Downgrade | Hold (Buy) |
11.15 (15.25) |
36.77% | Details | |
| 8/22/2022 | Clarus | CRXT | Downgrade | Hold (Buy) |
0.21 (0.10) |
-52.38% | Details | |
| 6/30/2022 | Heron Therapeutics | HRTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/29/2022 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2022 | Xenon Pharmaceuticals | XENE | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2022 | Evolus | EOLS | New Coverage | Buy (N/A) |
11.51 (11.56) |
0.43% | Details | |
| 5/25/2022 | Verrica Pharmaceuticals | VRCA | Downgrade | Hold (Buy) |
5.56 (6.90) |
24.1% | Details | |
| 5/25/2022 | Verrica Pharmaceuticals | VRCA | Downgrade | Hold (Buy) |
5.56 (5.56) |
0% | Details | |
| 5/24/2022 | Liquidia Technologies | LQDA | Maintain | Buy (Buy) |
|
Details | ||
| 5/17/2022 | Clarus | CRXT | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2022 | CorMedix | CRMD | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2022 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 5/12/2022 | Clearside Biomedical | CLSD | Maintain | Hold (Hold) |
|
Details | ||
| 5/10/2022 | Heron Therapeutics | HRTX | Maintain | Buy (Buy) |
|
Details | ||
| 5/6/2022 | Aerie Pharma | AERI | Maintain | Buy (Buy) |
|
Details | ||
| 5/5/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 4/14/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 4/14/2022 | Collegium Pharmaceutical | COLL | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Xenon Pharmaceuticals | XENE | Maintain | Buy (Buy) |
|
Details | ||
| 4/5/2022 | Collegium Pharmaceutical | COLL | Maintain | Buy (Buy) |
|
Details | ||
| 3/31/2022 | Akebia Therapeutics | AKBA | Downgrade | Hold (Buy) |
0.83 (1.39) |
67.47% | Details | |
| 3/31/2022 | Clarus | CRXT | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2022 | CorMedix | CRMD | Maintain | Buy (Buy) |
|
Details | ||
| 3/30/2022 | Tricida | TCDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2022 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | Revance Therapeutic | RVNC | Maintain | Buy (Buy) |
|
Details | ||
| 3/18/2022 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2022 | Liquidia Technologies | LQDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/15/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2022 | Liquidia Technologies | LQDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2022 | Amphastar Pharmaceuticals | AMPH | Maintain | Hold (Hold) |
|
Details | ||
| 3/10/2022 | Graybug Vision | GRAY | Maintain | Hold (Hold) |
|
Details | ||
| 3/10/2022 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2022 | Revance Therapeutic | RVNC | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2022 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2022 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Akebia Therapeutics | AKBA | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Omeros Corp. | OMER | Maintain | Hold (Hold) |
|
Details | ||
| 3/1/2022 | Zynerba Pharmaceuticals | ZYNE | Maintain | Hold (Hold) |
|
Details | ||
| 3/1/2022 | Revance Therapeutic | RVNC | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Heron Therapeutics | HRTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Zogenix, Inc. | ZGNX | Maintain | Hold (Hold) |
|
Details | ||
| 2/25/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2022 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2022 | Akebia Therapeutics | AKBA | Maintain | Buy (Buy) |
|
Details | ||
| 2/22/2022 | Esperion Therapeutics | ESPR | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Collegium Pharmaceutical | COLL | Maintain | Buy (Buy) |
|
Details | ||
| 2/4/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 2/1/2022 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 1/19/2022 | Zogenix, Inc. | ZGNX | Downgrade | Hold (Buy) |
15.64 (26.68) |
70.59% | Details | |
| 1/10/2022 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2021 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2021 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2021 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2021 | Flexion Therapeutics | FLXN | Downgrade | Hold (Buy) |
9.17 (9.12) |
-0.55% | Details | |
| 10/6/2021 | Clarus | CRXT | New Coverage | Buy (N/A) |
4.06 (0.10) |
-97.54% | Details | |
| 9/28/2021 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2021 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2021 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2021 | Graybug Vision | GRAY | Downgrade | Hold (Buy) |
4.11 (5.50) |
33.82% | Details | |
| 3/2/2021 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2021 | GW Pharma | GWPH | Downgrade | Hold (Buy) |
146.25 (218.96) |
49.72% | Details | |
| 1/26/2021 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2020 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2020 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
12.26 (40.31) |
228.79% | Details | |
| 7/6/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2020 | Zynerba Pharmaceuticals | ZYNE | Downgrade | Hold (Buy) |
3.37 (1.30) |
-61.42% | Details | |
| 6/30/2020 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2020 | Verrica Pharmaceuticals | VRCA | New Coverage | Buy (N/A) |
8.67 (5.56) |
-35.87% | Details | |
| 2/20/2020 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Dermira | DERM | Downgrade | Hold (Buy) |
18.76 (3.58) |
-80.92% | Details | |
| 1/8/2020 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2019 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2019 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | Aerie Pharma | AERI | Maintain | Buy (Buy) |
|
Details | ||
| 10/30/2019 | Dermira | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | Zynerba Pharmaceuticals | ZYNE | New Coverage | Buy (N/A) |
8.05 (3.37) |
-58.14% | Details | |
| 10/21/2019 | Zogenix, Inc. | ZGNX | New Coverage | Buy (N/A) |
42.59 (15.64) |
-63.28% | Details | |
| 9/19/2019 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2019 | Alder Biopharm | ALDR | Downgrade | Hold (Buy) |
10.06 (18.88) |
87.67% | Details | |
| 8/9/2019 | Clearside Biomedical | CLSD | Downgrade | Hold (Buy) |
1.28 (1.32) |
3.13% | Details | |
| 6/26/2019 | Alder Biopharm | ALDR | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2019 | Acer Therapeutics | ACER | Downgrade | Hold (Buy) |
19.28 (0.90) |
-95.33% | Details | |
| 6/3/2019 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
9.11 (2.69) |
-70.47% | Details | |
| 5/9/2019 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2019 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2019 | Dermira | DERM | Maintain | Buy (Buy) |
|
Details | ||
| 3/20/2019 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Buy (N/A) |
26.33 (11.50) |
-56.32% | Details | |
| 3/13/2019 | Amphastar Pharmaceuticals | AMPH | Downgrade | Hold (Buy) |
24.17 (38.65) |
59.91% | Details | |
| 3/5/2019 | Adamas Pharmaceuticals | ADMS | Downgrade | Hold (Buy) |
12.15 (8.22) |
-32.35% | Details | |
| 12/31/2018 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2018 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2018 | Acer Therapeutics | ACER | New Coverage | Buy (N/A) |
17.24 (19.28) |
11.83% | Details | |
| 11/9/2018 | Amphastar Pharmaceuticals | AMPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Clearside Biomedical | CLSD | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2018 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2018 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | Corium International Inc. | CORI | Downgrade | Hold (Buy) |
33.85 (103.12) |
204.64% | Details | |
| 8/20/2018 | Liquidia Technologies | LQDA | New Coverage | Buy (N/A) |
14.00 (13.81) |
-1.36% | Details |
